今开:0.0572 | 昨收:0.0545 |
最高:0.0572 | 最低:0.0571 |
涨停价:0.0 | 跌停价:0.0 |
总市值:698484.0 |
柏勒罗丰治疗(BLPH)2023-01-05 21:42
$柏勒罗丰治疗(BLPH)$ 8-K Current report, item 1.01 Accession Number: 0001600132-23-000003 Act: 34 Size: 157 KB 网页链接查看全文
柏勒罗丰治疗(BLPH)2023-11-22 05:25
$柏勒罗丰治疗(BLPH)$ 8-K Current report, item 5.02 Accession Number: 0001104659-23-120348 Act: 34 Size: 199 KB 网页链接查看全文
柏勒罗丰治疗(BLPH)2023-11-15 06:55
$柏勒罗丰治疗(BLPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-23-019044 Act: 34 Size: 5 MB 网页链接查看全文
柏勒罗丰治疗(BLPH)2023-11-07 05:35
$柏勒罗丰治疗(BLPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-23-114775 Act: 34 Size: 947 KB 网页链接查看全文
柏勒罗丰治疗(BLPH)2023-10-27 22:55
$柏勒罗丰治疗(BLPH)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-23-112046 Act: 34 Size: 1 MB 网页链接查看全文
柏勒罗丰治疗(BLPH)2023-10-17 02:05
$柏勒罗丰治疗(BLPH)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-109317 Act: 33 Size: 30 KB 网页链接查看全文
柏勒罗丰治疗(BLPH)2023-10-17 18:05
$柏勒罗丰治疗(BLPH)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001760460-23-000009 Act: 34 Size: 50 KB 网页链接查看全文
柏勒罗丰治疗(BLPH)2023-10-13 22:35
$柏勒罗丰治疗(BLPH)$ 8-K Current report, item 5.02 Accession Number: 0001104659-23-109006 Act: 34 Size: 193 KB 网页链接查看全文
柏勒罗丰治疗(BLPH)2023-10-17 02:05
$柏勒罗丰治疗(BLPH)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-109313 Act: 33 Size: 30 KB 网页链接查看全文
临床治疗药物公司Bellerophon(BLPH.O)盘初跳涨18%,触及熔断。 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, item 5.02 Accession Number: 0001104659-23-120348 Act: 34 Size: 199 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-23-019044 Act: 34 Size: 5 MB 网页链接
$柏勒罗丰治疗(BLPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-23-114775 Act: 34 Size: 947 KB 网页链接
$柏勒罗丰治疗(BLPH)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-23-112046 Act: 34 Size: 1 MB 网页链接
$柏勒罗丰治疗(BLPH)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001760460-23-000010 Act: 34 Size: 50 KB 网页链接
$柏勒罗丰治疗(BLPH)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001760460-23-000009 Act: 34 Size: 50 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001760460-23-000008 Size: 10 KB 网页链接
$柏勒罗丰治疗(BLPH)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-109315 Act: 33 Size: 30 KB 网页链接
$柏勒罗丰治疗(BLPH)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-109316 Act: 33 Size: 30 KB 网页链接
$柏勒罗丰治疗(BLPH)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-109317 Act: 33 Size: 30 KB 网页链接